tiprankstipranks
Nano-X Imaging Ltd. (NNOX)
NASDAQ:NNOX
US Market
Want to see NNOX full AI Analyst Report?

Nano-X Imaging (NNOX) Earnings Dates, Call Summary & Reports

2,561 Followers

Earnings Data

Report Date
Aug 18, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-0.23
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Jun 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presented a mix of operational progress and commercial momentum — including deployments at RadNet, large partner agreements (~360 potential systems), accelerating teleradiology and AI revenues, and cross-division integrations — but these positives are offset by material near-term financial challenges: cash decline, substantial doubt about going concern, continued quarterly cash burn, increased operating losses, withdrawal of 2026 revenue guidance, and timing delays converting agreements into recognized revenue. The tone is cautiously constructive on execution and long-term opportunity but guarded on short-term financial health.
Company Guidance
The company withdrew its prior 2026 revenue target (previously cited as $35 million) and will no longer provide annual revenue guidance, instead focusing on operational milestones; Q1 revenue was $4.3M (up from $2.8M), with teleradiology $3.1M (GAAP gross profit $0.7M, ~24% margin; non‑GAAP gross profit $1.1M, ~36% margin), AI/software $1.0M, and imaging systems $167K (including two Nanox.CONNECT sales of $118K); GAAP net loss was $14.3M (non‑GAAP loss $11.1M), GAAP gross loss $2.6M (non‑GAAP gross loss $2.2M), R&D $4.8M, S&M $2.2M, G&A $5.2M. Commercially, the company has partner agreements representing ~360 potential CapEx system sales over 2–3 years (partner estimate ~60 this year), plans to deploy 21 Nano‑X Imaging Network sites (one retail site scanning; two systems recently delivered), and has an operational RadNet ARC; international expansion includes Greece, Romania, Peru, Argentina, Czech Republic and France. Cash and equivalents plus short‑/long‑term deposits totaled $44.2M as of 3/31/26 (prelim cash net of short‑term bank loan ~ $27M), negative operating cash flow was $14M, capex was $1.8M, PPE net $30.6M, shares outstanding ~69.6M and ~1.0M RSUs granted; management expects Q2 to be better than Q1, a Q3–Q4 deployment ramp, AI gross margins “in the 80s” with cash‑breakeven now more likely in early 2027 (may be delayed a quarter), and anticipates sequential expense reductions from restructurings (including ~15 headcount reductions in Israel), while noting cash is sufficient for at least one year but substantial doubt about going concern remains.
Quarterly Revenue Growth
Total revenue of $4.3M in Q1 2026 vs. $2.8M year-ago, an increase of ~$1.5M (+53.6%), driven by consolidation of Nanox Health IT (VasoHealthcare) and higher teleradiology volumes.
Teleradiology Momentum and Margin Improvement
Teleradiology revenue rose to $3.1M from $2.6M (+19.2%). GAAP gross profit from teleradiology improved to $0.7M (~24% margin) from $0.4M (~17%), with non-GAAP gross profit of $1.1M (~36%).
Rapid AI/Software Revenue Increase
AI and software revenue grew to $1.0M from $0.2M (approximately +400%), with non-GAAP gross profit improving to $0.3M from $0.08M, and notable commercial AI deployments (e.g., Hellenic Air Force Hospital) transitioning to revenue-generating status.
Commercial Deployment Milestones (RadNet and Partners)
Nanox.ARC is operational and integrated in routine clinical workflow at a RadNet site. The company signed multiple U.S. distributor agreements representing potential for ~360 CapEx system sales over 2–3 years and expects initial partner sales (one partner estimated ~60 this year).
Nano-X Imaging Network & International Distribution Progress
Proof-of-concept Nano-X Imaging Network sites beginning to scan (one retail site active; two sites received systems), and a distribution agreement signed in Peru (TopMed SAC) with additional Latin America and European partnerships in advanced stages.
Cross-Division Integration and Pipeline Growth
Integration between Health IT, Nanox.AI, Nanox.ARC, and USARAD completed for demos and client use; cross-division lead generation reported as growing weekly, providing opportunities for bundled sales (systems + AI + teleradiology + IT).
OEM and Technical Progress
Varex X-ray tubes nearing final integration as main tube source; Oak Ridge National Lab prototypes progressing with anticipated testing completion and delivery in early Q3.
Cost Optimization Actions
Company implemented restructuring actions including reduction in Israel headcount (15 employees) and is executing a restructuring in South Korea to optimize economics and reduce burn; management expects sequential operating expense decline.

Nano-X Imaging (NNOX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NNOX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2026
2026 (Q2)
- / -
-0.23
Jun 25, 2026
2026 (Q1)
-0.17 / -0.20
-0.214.76% (<+0.01)
Apr 20, 2026
2025 (Q4)
-0.20 / -0.20
-0.214.76% (<+0.01)
Nov 20, 2025
2025 (Q3)
-0.21 / -0.21
-0.238.70% (+0.02)
Aug 12, 2025
2025 (Q2)
-0.19 / -0.23
-0.230.00% (0.00)
May 22, 2025
2025 (Q1)
- / -
-0.21
Mar 31, 2025
2024 (Q4)
-0.19 / -0.21
-0.210.00% (0.00)
Nov 21, 2024
2024 (Q3)
-0.22 / -0.23
-0.3737.84% (+0.14)
Aug 20, 2024
2024 (Q2)
-0.22 / -0.23
-0.3125.81% (+0.08)
May 28, 2024
2024 (Q1)
- / -
-0.21
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NNOX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jun 25, 2026
$1.57$0.88-44.01%
Apr 20, 2026
$2.85$2.15-24.39%
Nov 20, 2025
$3.03$3.45+13.86%
Aug 12, 2025
$4.71$4.46-5.31%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nano-X Imaging Ltd. (NNOX) report earnings?
Nano-X Imaging Ltd. (NNOX) is schdueled to report earning on Aug 18, 2026, Before Open (Confirmed).
    What is Nano-X Imaging Ltd. (NNOX) earnings time?
    Nano-X Imaging Ltd. (NNOX) earnings time is at Aug 18, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NNOX EPS forecast?
          Currently, no data Available

          Nano-X Imaging (NNOX) Earnings News

          NNOX Unveils Bold Expansion Strategy, Igniting Stock Surge
          Premium
          Market News
          NNOX Unveils Bold Expansion Strategy, Igniting Stock Surge
          3y ago